Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Apnimed Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Apnimed Inc (APMD) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
-29.40 %
Q2 2026
Net Margin
1,042.51 %
Q2 2026

Key Findings: Apnimed Inc vs Its Competitors

  • Peer revenue share: Apnimed Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

APMD Sales vs. its Competitors, Q2 2026

Apnimed Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/APMD/competitors
https://api.csimarket.com/api/v1/companies/APMD/relationships
https://api.csimarket.com/api/v1/companies/APMD/similar
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API

For context: the Major Pharmaceutical Preparations industry grew revenue 8.9% year over year, combined, vs -29.4% for Apnimed Inc. Apnimed Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

Apnimed Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Apnimed, Inc. - - - -
High-Confidence Competitors (1) 100% 100% 0% 0%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q2 2026

100%market share
  • Apnimed Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Apnimed Inc and its 0 tracked competitors.

See Apnimed Inc's full market share breakdown »

APMD Stock Performance relative to its Competitors

APMD Competitors (weighted) Percent change over the selected range

Apnimed Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
0%beat U.S.A. 500
High-Confidence
(0 of 1)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Apnimed, Inc. - -
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (1) 40.4% 63.2%
Similar-Size Competitors (0) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Apnimed Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

APMD Stock Performance relative to High-Confidence Competitors

APMD High-Confidence Competitors (equal-weighted, 1) Percent change over the selected range

Apnimed Inc's Competitors Named by the Company

Competitive relationships identified from Apnimed Inc reports and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Inspire Medical Systems inc Company report 85% 2022 to 2026 3
Competitor Evidence Detail

Company report basis, confidence, active dates and source counts for Apnimed Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from Apnimed Inc reports (named-competitor disclosures) and corroborating sources. Confidence reflects evidence strength.

Get the full CSIMarket dataset: Subscribe API Connect Your AI